EUVIMEDEUVIMED entdecken
Multizentrische Studie

Intravitreal Dexamethasone as a Rescue for Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration with Persistent Disease Activity and High Treatment Demand

Marlena Pietzuch, Irmela Mantel, Aude Ambresin, Christoph Tappeiner, Dana Nagyova, Guy Donati, Isabel B Pfister, Christin Schild, Justus G Garweg

Journal of Ocular Pharmacology and Therapeutics · 2024

DOI: 10.1089/jop.2023.0105 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2024. Verfasst von Marlena Pietzuch und 8 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Eye Institute and Clinic for Vitreoretinal Diseases, Berner Augenklinik, Bern, Switzerland. Hauptthemen laut MEDLINE: Dexamethasone, Intravitreal Injections, Vascular Endothelial Growth Factor A, Ranibizumab. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneIntravitreal InjectionsVascular Endothelial Growth Factor ARanibizumabAngiogenesis InhibitorsHumansRetrospective StudiesMaleFemaleAged, 80 and overAgedVisual AcuityMacular DegenerationReceptors, Vascular Endothelial Growth FactorDrug ImplantsRecombinant Fusion ProteinsGlucocorticoidsWet Macular DegenerationLongitudinal Studies

Stichwörter der Autor:innen

Ozurdexburden of treatmentdexamethasone implantdisease stabilityintravitreal anti-VEGF therapyneovascular age-related macular degeneration

Substanzen

DexamethasoneVascular Endothelial Growth Factor ARanibizumabAngiogenesis InhibitorsafliberceptReceptors, Vascular Endothelial Growth FactorDrug ImplantsRecombinant Fusion ProteinsGlucocorticoids

Autor:innen und Institutionen

  • Swiss Eye Institute and Clinic for Vitreoretinal Diseases, Berner Augenklinik, Bern, Switzerland.
  • Department of Ophthalmology, Bern University Hospital, Bern, Switzerland.
  • Department of Ophthalmology, University of Lausanne, Jules Gonin Eye Hospital, Lausanne, Switzerland.
  • Swiss Visio Clinic Montchoisi, Lausanne, Switzerland.
  • Department of Ophthalmology, Pallas Kliniken, Olten, Switzerland.
  • Department of Ophthalmology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Zitieren

APA

Pietzuch, M., Mantel, I., Ambresin, A., Tappeiner, C., Nagyova, D., Donati, G., Pfister, I. B., Schild, C., & Garweg, J. G. (2024). Intravitreal Dexamethasone as a Rescue for Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration with Persistent Disease Activity and High Treatment Demand. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2023.0105

Vancouver

Pietzuch M, Mantel I, Ambresin A, Tappeiner C, Nagyova D, Donati G, et al. Intravitreal Dexamethasone as a Rescue for Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration with Persistent Disease Activity and High Treatment Demand. Journal of Ocular Pharmacology and Therapeutics. 2024. doi:10.1089/jop.2023.0105

BibTeX
@article{Pietzuch2024,
  author = {Pietzuch, Marlena and Mantel, Irmela and Ambresin, Aude and Tappeiner, Christoph and Nagyova, Dana and Donati, Guy and Pfister, Isabel B and Schild, Christin and Garweg, Justus G},
  title = {Intravitreal Dexamethasone as a Rescue for Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration with Persistent Disease Activity and High Treatment Demand},
  journal = {Journal of Ocular Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.1089/jop.2023.0105}
}
Kostenlos starten →